PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 24, 2013Heart151 citations

Recent advances in hypertension in sub-Saharan Africa

View Full Paper
OOOkechukwu S. OgahBRBrian Rayner

Key Points

  • This review aims to gather and summarize recent information on hypertension in sub-Saharan Africa since 2008.
  • Literature search conducted in Pubmed, Embase, WHO Global Cardiovascular Infobase, and others

Structured PICO

P
Population
Individuals in sub-Saharan Africa
O
Outcome
Prevalence of hypertension

The prevalence of hypertension in sub-Saharan Africa is estimated at 16.2%, highlighting a growing epidemic driven by urbanization and lifestyle changes.

Abstract

BACKGROUND: Hypertension was once considered rare in sub-Saharan Africa (SSA), but currently it has become a widespread problem with immense socioeconomic importance. The purpose of this review is to summarise new information on hypertension in SSA that has been published since the last major review in 2008. METHODS AND RESULTS: A literature search was performed in Pubmed, Embase, WHO Global Cardiovascular Infobase, African Journal On-Line, and African Index Medicus using the following search criteria: hypertension, high blood pressure, and Africa/SSA. Epidemiological surveys that used the WHO STEPS approach or similar methods were also included. The overall prevalence of hypertension in SSA was estimated at 16.2% (95% CI 14.2% to 20.3%) with an estimated number of hypertensive individuals to be 74.7 million. The prevalence of hypertension varies widely from country to country. It is projected that the number of affected individuals will increase by 68% (125.5 million) by 2025. Mass migration of rural Africans to urban areas and rapid changes in lifestyle and risk factors account for the rising prevalence of hypertension. CONCLUSIONS: Proactive public health interventions at a population level need to be introduced to control the growing hypertension epidemic, and there needs to be a major improvement in access to hypertensive care for the individual. There is an important need for better epidemiological data and hypertension related outcome trials in SSA.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ogah et al. (2013) studied this question.

synapsesocial.com/papers/6a215d6d5c0c8498e257f204https://doi.org/10.1136/heartjnl-2012-303227
Ask AI
Helpful
Bookmark
Share
View Full Paper